|
Synonyms: LAS-100977
Compound class:
Synthetic organic
Comment: Abediterol (AS100977) is an investigational long-acting beta(β)-agonist (LABA) [1], in development as a once-daily treatment for asthma [2] and potentially COPD. Currently available LABAs approved for use by asthmatic patients include salmeterol, formoterol and olodaterol.
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| Phase 2a first-in-patient clinical trial results are published in [2]. The agent was generally well tolerated, producing a safe, potent, rapid and long-acting bronchodilatory effect in patients with persistent mild-to-moderate asthma. |